This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Selank administered intraperitoneally at 0.3 mg/kg prevented ethanol-induced hyperlocomotion and blocked the manifestation of motor sensitization in male DBA/2 mice, indicating modulation of ethanol's motivational effects.
Why it matters
Understanding how Selank modulates alcohol-induced behaviors could help develop new treatments for alcohol-related disorders and expand knowledge on peptide-based anxiolytics.
How the study worked
Male DBA/2 mice were given intraperitoneal injections of Selank, naloxone, or Afobazole before ethanol administration. Locomotor activity and behavioral sensitization were measured to assess the effects of these compounds on ethanol-induced stimulation.
What this study cannot tell us
The study was conducted only in male DBA/2 mice, limiting generalizability to other strains, species, or females. The evidence strength and study type were not specified.
Read the original research
Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice.
Bulletin of experimental biology and medicine, 162(1), 56-59
Citation
Kolik, L G; Nadorova, A V; Seredenin, S B. (2016). Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice.. Bulletin of experimental biology and medicine, 162(1), 56-59.